Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 7,382 shares of Cardlytics stock in a transaction dated Friday, October 2nd. The stock was sold at an average price of $2.53, for a total value of $18,676.46. Following the completion of the sale, the chief executive officer directly owned 138,906 shares in the company, valued at $351,432.18. This trade represents a 5.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Amit Gupta also recently made the following trade(s):
- On Thursday, October 1st, Amit Gupta sold 10,351 shares of Cardlytics stock. The stock was sold at an average price of $2.71, for a total value of $28,051.21.
- On Tuesday, August 18th, Amit Gupta sold 6,676 shares of Cardlytics stock. The shares were sold at an average price of $4.03, for a total value of $26,904.28.
- On Monday, August 17th, Amit Gupta sold 6,785 shares of Cardlytics stock. The shares were sold at an average price of $3.97, for a total value of $26,936.45.
- On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The stock was sold at an average price of $4.39, for a total value of $42,319.60.
Cardlytics Stock Performance
NASDAQ:CDLX traded down $0.11 during trading hours on Friday, reaching $2.53. The stock had a trading volume of 75,648 shares, compared to its average volume of 84,032. The stock has a market capitalization of $14.70 million, a PE ratio of -0.14 and a beta of 0.71. Cardlytics, Inc. has a 52 week low of $2.47 and a 52 week high of $26.70. The company has a 50 day moving average price of $3.83 and a two-hundred day moving average price of $5.90.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on CDLX shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Cardlytics in a research note on Wednesday, July 8th. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Thursday, June 18th. Finally, Wall Street Zen downgraded Cardlytics from a “hold” rating to a “sell” rating in a research report on Saturday, September 19th. One analyst has rated the stock with a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell” and an average price target of $10.00.
View Our Latest Stock Report on CDLX
Hedge Funds Weigh In On Cardlytics
An institutional investor recently raised its position in Cardlytics stock. Renaissance Technologies LLC boosted its position in shares of Cardlytics, Inc. (NASDAQ:CDLX – Free Report) by 108.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 112,500 shares of the company’s stock after purchasing an additional 58,500 shares during the period. Renaissance Technologies LLC owned about 0.20% of Cardlytics worth $118,000 as of its most recent SEC filing. 68.10% of the stock is currently owned by institutional investors.
About Cardlytics
Cardlytics, Inc is an advertising technology company that connects marketers with consumers through financial institutions. Its platform uses transaction-based insights to help advertisers reach customers with relevant offers and measure the impact of advertising on consumer spending.
Cardlytics’ services are integrated into banking and financial applications, where consumers may receive personalized cash-back offers, discounts and other promotions based on their shopping activity. Participating financial institutions can use the platform to provide additional value to customers while generating advertising revenue.
The company serves advertisers across categories such as retail, dining, travel and financial services, and works with banks and other financial institutions primarily in the United States and the United Kingdom.
See Also
- Five stocks we like better than Cardlytics
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
